News

prueba

February 2024


More info

Tumor regulatory T cells and heparan sulfate

November 2023

Cellular & Molecular Immunology publishes the important role of certain tumor carbohydrates in the induction of regulatory T cells in cancer. The results indicate that structures related to tumor-associated heparan sulfate induce this type of suppressor cells. The study was conducted at the Universidad Complutense, Hospital Clínico San Carlos, CIB-CSIC and INMUNOTEK.
More info

Aeroallergens of fungal origin: A review

November 2023

Molecular Immunology publishes a comprehensive review on the importance of fungi as aeroallergens. Not only spores, but also fragments derived from them can cause severe forms of respiratory allergies. All this is updated and discussed in this review by members of INMUNOTEK's R&D department.
More info

Mannan-conjugated polymerized birch allergoids

Conjugados alergoidesOctober 2023

A new phase 2 clinical randomized clinical trial using the new mannan-conjugated polymerized allergoids has been published in Allergy. This study was conducted in Germany with birch (Betula) pollen, a major cause of respiratory allergies.
More info

Study on cross-reactivity between bacteria and viruses

August 2023

A study on the potential of bacteria to induce antiviral responses has been published in Frontiers in Immunology. The study focused on respiratory viruses and bacteria, which are common respiratory pathogens. The results indicate the existence of common peptides between viruses and bacteria, such as those contained in MV130.
More info

Results with mannan-conjugated allergoids in EAACI

Conjugados alergoidesJune 2023

The clinical results obtained with the new mannan-conjugated allergoids for immunotherapy against birch pollen allergy have been presented in Hamburg (Germany) during the annual EAACI congress. These studies include the first phase 3 results showing their safety and efficacy.
More info

Allergen exposome and atopic phenotype in Tenerife

May 2023

The allergen exposome was studied in allergic subjects living in Tenerife (Canary Islands - Spain). The results published in IJMS show IgE sensitization patterns according to the atopic phenotype of the patients studied. The study was conducted at the Hospital Universitario de Canarias in collaboration with INMUNOTEK.
More info

Allergens of Alternaria alternata: A Review

May 2023

Journal of Fungi publishes a comprehensive review on Alternaria alternata, its ecology and major allergens. Fungi in general and Alternaria alternata in particular are an important source of aeroallergens causing severe respiratory allergies such as bronchial asthma. All this has been updated and discussed by the Applied Science Team of INMUNOTEK in the above mentioned publication.
More info

Results with MV140 in North American Patients

May 2023

The results obtained with MV140 in North American patients with recurrent uncomplicated urinary tract infections were presented at the annual meeting of the American Urological Association in Chicago. The study conducted in North America (Canada) under real-world conditions indicates that MV140 has a high degree of efficacy and safety in the prevention of this type of infection.
More info

ERS Research Seminar

April 2023

INMUNOTEK has sponsored the ERS (European Respiratory Society) Research Seminar that has taken place in Berlin with the title "Preventing asthma - are we ready to translate epidemiological and mechanistic studies into reality?" Leading researchers in the field were invited to present their latest results with new therapeutic approaches such as that offered by mucosal bacterial immunotherapy.
More info